From Budd-Chiari syndrome to acquired von Willebrand syndrome: Thrombosis and bleeding complications in the myeloproliferative neoplasms

Keyphrases

• Thrombosis 100%
• Myeloproliferative Neoplasms 100%
• Von Willebrand Disease 100%
• Bleeding Complications 100%
• Budd-Chiari Syndrome 100%
• Bleeding 50%
• Special Circumstances 50%
• Risk Reduction 25%
• Risk Factors 25%
• Treatment Strategy 25%
• Cell Adhesion 25%
• Essential Thrombocythemia 25%
• Myelofibrosis 25%
• Polycythemia Vera 25%
• Risk Stratification 25%
• Thrombotic 25%
• Clinical High Risk 25%
• Therapeutic Goals 25%
• Hemorrhagic Complications 25%
• Advanced Age 25%
• Thrombosis Risk 25%
• Risk Treatment 25%
• Practice Patterns 25%
• Anticoagulation 25%
• Vascular Bed 25%
• Mutational Status 25%
• Venous Thrombosis 25%
• Cardiovascular Risk Reduction 25%
• Risk Classification 25%
• Antiplatelet Therapy 25%
• Inflammatory Stress 25%
• Perioperative Period 25%
• Thrombotic Complications 25%
• Tailored Therapy 25%
• Mutational Profile 25%
• Traditional Factor 25%
• Unusual Sites 25%
• Abnormal Cells 25%
• Cytoreduction 25%
• Factor Strategy 25%

Medicine and Dentistry

• Bleeding 100%
• Thrombosis 100%
• Budd-Chiari Syndrome 100%
• Myeloproliferative Neoplasm 100%
• Cardiovascular Risk 20%
• Anticoagulation 20%
• Phlebothrombosis 20%
• Antiplatelet 20%
• Risk Reduction 20%
• Perioperative Period 20%
• Polycythemia vera 20%
• Myelofibrosis 20%
• Essential Thrombocythaemia 20%
• Cell Adhesion 20%